Fisher & Paykel Healthcare Ltd. v ResMed Ltd

Link copied
Case Copied 75 min read

IP AUSTRALIA

AUSTRALIAN PATENT OFFICE

Fisher & Paykel Healthcare Ltd. v ResMed Ltd. [2016] APO 48

Patent Application:                2009221630

Title:Mask system

Patent Applicant:                   ResMed Ltd.

Opponent:  Fisher & Paykel Healthcare Ltd.

Delegate:  Dr W.E. Guinea

Decision Date:  15 July 2016

Hearing Date:  26 and 27 May 2016, in Sydney

Catchwords:  PATENTS – section 59 – opposition to the grant of a patent – novelty – inventive step – manner of manufacture – fair basis – some claims found to lack inventive step – no other grounds successful – Regulation 5.23 invoked

Representation:  Counsel for the Applicant: Angus Lang

Patent Attorney for the Applicant: Robynne Sanders and Louis Italiano of DLA Piper, Paul Green, Julian Magarey and Mark Abourizk of ResMed Ltd.

Counsel for the Opponent: Cameron Moore SC and Andrew Fox

Patent Attorney for the Opponent: Joe Seisdedos and Gilulia Fimmano of AJ Park, Ben Halberg of Fisher & Paykel Healthcare Ltd.

IP AUSTRALIA

AUSTRALIAN PATENT OFFICE

Patent Application:                2009221630

Title:Mask system

Patent Applicant:                   ResMed Ltd.

Date of Decision:                   15 July 2016

DECISION

The Opposition is successful.  Claims 1, 2, 3, 4, 6, 7, 8, 9, 10, 11, 12, 14, 15, 16, 17, 18, 19 and 20 are found to lack inventive step.  All other grounds of opposition were unsuccessful.

I invoke Regulation 5.23 with regard to document D4.

I allow the proposed amendments to the statement of grounds and particulars dated 8 June 2016.

The Applicant has two months from the date of this decision to propose amendments that overcome the deficiency with respect to inventive step.

No award of costs is made.

REASONS FOR DECISION

Background

1.   Patent application 2009221630 (“the opposed application”) entered national phase in Australia on 31 August 2010 from PCT application PCT/AU2009/000241.

2.   ResMed Ltd. (“the Applicant”) requested examination on 14 November 2012, and the opposed application was advertised as accepted on 17 July 2014.

3.   A notice of opposition was filed by Fisher & Paykel Healthcare Ltd. (“the Opponent”) on 17 October 2014.  The Opponent filed a statement of grounds and particulars (“original SGP”) on 19 January 2015.

4.   Evidence in support (“EIS”) was filed on 17 April 2015.  This comprised:

·     a first statutory declaration dated 9 April 2015 by Mr Alistair Edwin McAuley (“McAuley1”) with supporting exhibits AM-1 and AM-2;

·     a second statutory declaration dated 14 April 2015 by Mr Alistair Edwin McAuley (“McAuley2”);

·     a third statutory declaration dated 17 April 2015 by Mr Alistair Edwin McAuley (“McAuley3”);

·     a statutory declaration dated 16 April 2015 by Mr Troy Alan Baker (“Baker”) with supporting exhibit TB-1;

·     a statutory declaration dated 17 April 2015 by Mr Christopher Earl Nightingale (“Nightingale”); and

·     a statutory declaration dated 2 April 2015 by Professor David Maurice Rapoport (“Rapoport”) with supporting exhibit DR-1.

5.   Evidence in answer (“EIA”) was filed on 17 July 2015.  This comprised:

·     a statutory…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Fisher & Paykel Healthcare Ltd. v ResMed Ltd and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2016] APO 48
Decision Date

CaseChat Overview and Summary

Fisher & Paykel Healthcare Ltd. opposed the grant of a patent to ResMed Ltd. The patent related to a mask system for the treatment of sleep disordered breathing. The Opposition was heard in May 2016 and the Delegate found that the Opposition was successful in relation to inventive step. The Delegate found that the mask system did not have an inventive step in respect of claims 1, 2, 3, 4, 6, 7, 8, 9, 10, 11, 12, 14, 15, 16, 17, 18, 19 and 20. The Delegate found that the claims were not novel, lacked a manner of manufacture and were not fairly based. The Delegate allowed the Applicant to propose amendments to overcome the deficiency with respect to inventive step. The Delegate made no award of costs.

Orders

Orders of the court

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

Ratio Decidendi

Legal Principle Established